Solveig Sand-Hanssen Hofvind
Cody M. Schopf,
Ojas A. Ramwala,
Kathryn P. Lowry,
Solveig Sand-Hanssen Hofvind,
M. Luke Marinovich,
Nehmat Houssami
m.fl.:
Artificial Intelligence-Driven Mammography-Based Future Breast Cancer Risk Prediction: A Systematic Review
Journal of the American College of Radiology 2024 DOI
Nataliia Moshina,
Axel Gräwingholt,
Kristina Lång,
Ritse Mann,
Tone Hovda,
Solveig Kristin Roth Hoff
m.fl.:
Digital breast tomosynthesis in mammographic screening: false negative cancer cases in the To-Be 1 trial
Susanne Fogh Jørgensen,
Silje Sagstad,
Javier Louro,
Marta Román,
Xavier Castells,
Solveig Sand-Hanssen Hofvind
m.fl.:
Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain
Sameer Bhargava,
Jonas Gjesvik,
Jonas Evensen Thy,
Marthe Larsen,
Solveig Sand-Hanssen Hofvind
:
Breast cancer-specific survival among immigrants and non-immigrants invited to BreastScreen Norway
Journal of Migration and Health 2024 DOI
Marthe Larsen,
Camilla Flåt Olstad,
Christoph I. Lee,
Tone Hovda,
Solveig Kristin Roth Hoff,
Marit Almenning Martiniussen
m.fl.:
Performance of an Artificial Intelligence System for Breast Cancer Detection on Screening Mammograms from BreastScreen Norway
Nadia Iqbal,
Paula Marianna Berstad,
Marit Solbjør,
Esperanza Diaz Perez,
Elzbieta Czapka,
Solveig Sand-Hanssen Hofvind
m.fl.:
Access to colorectal cancer screening for Pakistani immigrants in Norway – a qualitative study
Jessie J. J. Gommers,
Craig K. Abbey,
Fredrik Strand,
Sian Taylor-Phillips,
David J. Jenkinson,
Marthe Larsen
m.fl.:
Modeling Radiologists’ Assessments to Explore Pairing Strategies for Optimized Double Reading of Screening Mammograms
Tone Hovda,
Silje Sagstad,
Nataliia Moshina,
Einar Vigeland,
Solveig Sand-Hanssen Hofvind
:
Initial interpretation scores of screening mammograms and cancer detection in BreastScreen Norway
European Journal of Radiology 2024 DOI
Marie Burns Bergan,
Marthe Larsen,
Nataliia Moshina,
Hauke Bartsch,
Henrik Wethe Koch,
Hildegunn Siv Aase
m.fl.:
AI performance by mammographic density in a retrospective cohort study of 99,489 participants in BreastScreen Norway
European Radiology 2024 DOI
Nathalie Charlotte Støer,
Siri Vangen,
Deependra Singh,
Renee T. Fortner,
Solveig Hofvind,
Giske Ursin
m.fl.:
Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway
Henrik Wethe Koch,
Marthe Larsen,
Hauke Bartsch,
Marit Almenning Martiniussen,
Bodil Margrethe Styr,
Siri Fagerheim
m.fl.:
How do AI markings on screening mammograms correspond to cancer location? An informed review of 270 breast cancer cases in BreastScreen Norway
European Radiology 2024 DOI
Åsne Sørlien Holen,
Marit Almenning Martiniussen,
Marie Burns Bergan,
Nataliia Moshina,
Tone Hovda,
Solveig Sand-Hanssen Hofvind
:
Women's attitudes and perspectives on the use of artificial intelligence in the assessment of screening mammograms
Jonas Gjesvik,
Nataliia Moshina,
Christoph I. Lee,
Diana L. Miglioretti,
Solveig Sand-Hanssen Hofvind
:
Artificial Intelligence Algorithm for Subclinical Breast Cancer Detection
Julie Røgler Langås,
Anne Eskild,
Solveig Sand-Hanssen Hofvind,
Elisabeth Krefting Bjelland
:
The association of adolescent to midlife weight change with age at natural menopause: a population study of 263,586 women in Norway
American Journal of Epidemiology 2024 DOI
Wanja Kildal,
Karolina Urszula Cyll,
Joakim Kalsnes,
Rakibul Islam,
Frida M. Julbø,
Manohar Pradhan
m.fl.:
Deep learning for automated scoring of immunohistochemically stained tumour tissue sections – Validation across tumour types based on patient outcomes
Heliyon 2024 DOI
Nataliia Moshina,
Marie Burns Bergan,
åsne Sørlien Holen,
Gunhild Mangerud,
Solveig Sand-Hanssen Hofvind
:
Women's experience of the information provided along with invitation to participate in BreastScreen Norway
Journal of Medical Screening 2024 DOI
Tone Hovda,
Marthe Larsen,
Linda Romundstad,
Guro Kristine Kleivi Sahlberg,
Solveig Sand-Hanssen Hofvind
:
Breast cancer missed at screening; hindsight or mistakes?
Marthe Larsen,
Elsebeth Lynge,
Christoph I. Lee,
Kristina Lång,
Solveig Sand-Hanssen Hofvind
:
Mammographic density and interval cancers in mammographic screening: Moving towards more personalized screening
Julie Røgler Langås,
Anne Eskild,
Solveig Sand-Hanssen Hofvind,
Elisabeth Krefting Bjelland
:
The dose-response relationship of pre-menopausal alcohol consumption with age at menopause: a population study of 280 497 women in Norway
Tone Hovda,
Silje Sagstad,
Marthe Larsen,
Yan Chen,
Solveig Sand-Hanssen Hofvind
:
Screening outcome for interpretation by the first and second reader in a population-based mammographic screening program with independent double reading
Li Zhang,
Isabel Mosquera,
Eric Lucas,
Mary Luz Rol,
Andre L. Carvalho,
Partha Basu
m.fl.:
CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs
Nature Medicine 2023 DOI
Gisella Figlioli,
Amandine Billaud,
Thomas U. Ahearn,
Natalia N. Antonenkova,
Heiko Becher,
Matthias W. Beckmann
m.fl.:
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women
Henrik Wethe Koch,
Marthe Larsen,
Hauke Bartsch,
Kathinka Dæhli Kurz,
Solveig Sand-Hanssen Hofvind
:
Artificial intelligence in BreastScreen Norway: a retrospective analysis of a cancer-enriched sample including 1254 breast cancer cases
Leif Lukas Löfling,
Nathalie Charlotte Støer,
Sara Nafisi,
Giske Ursin,
Solveig Sand-Hanssen Hofvind,
Edoardo Botteri
:
Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women
åsne Sørlien Holen,
Marie Burns Bergan,
Christoph I. Lee,
Sophia Zackrisson,
Nataliia Moshina,
Hildegunn Siv Aase
m.fl.:
Early screening outcomes before, during, and after a randomized controlled trial with digital breast tomosynthesis
Jonas Evensen Thy,
Marthe Larsen,
Einar Vigeland,
Henrik Wethe Koch,
Tone Hovda,
Solveig Sand-Hanssen Hofvind
:
Early performance measures following regular versus irregular screening attendance in the population-based screening program for breast cancer in Norway
Marit Almenning Martiniussen,
Marthe Larsen,
Anne Sofie Frøyshov Larsen,
Tone Hovda,
Henrik Wethe Koch,
Atle Bjørnerud
m.fl.:
Norwegian radiologists’ expectations of artificial intelligence in mammographic screening – A cross-sectional survey
Nataliia Moshina,
Silje Sagstad,
åsne Sørlien Holen,
Heinrich August Backmann,
Line Camilla Westermann,
Solveig Sand-Hanssen Hofvind
:
Experience of pain during mammographic screening by three different compression paddles
Kristina Lång,
Viktoria Josefsson,
Anna-Maria Larsson,
Stefan Larsson,
Charlotte Högberg,
Hanna Sartor
m.fl.:
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study
Solveig Sand-Hanssen Hofvind,
Nadia Iqbal,
Jonas Evensen Thy,
Gunhild Mangerud,
Sameer Bhargava,
Sophia Zackrisson
m.fl.:
Effect of invitation letter in language of origin on screening attendance: randomised controlled trial in BreastScreen Norway
Nataliia Moshina,
Heinrich August Backmann,
Per Skaane,
Solveig Sand-Hanssen Hofvind
:
Mammographic features and risk of breast cancer death among women with invasive screen-detected cancer in BreastScreen Norway 1996–2020
Anouk H. Eijkelboom,
Linda de Munck,
Marthe Larsen,
Maarten J. Bijlsma,
Vivianne C.G. Tjan-Heijnen,
Carla H. van Gils
m.fl.:
Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study
Kaitlyn Tsuruda,
Solveig Kristin Roth Hoff,
Lars Andreas Akslen,
Solveig Sand-Hanssen Hofvind
:
Fatal and non-fatal breast cancers in women targeted by BreastScreen Norway: a cohort study
Helen Egestad,
Solveig Sand-Hanssen Hofvind,
Richard Fjellaksel
:
Utøvelse og utvikling av radiografifaget i Norge. En kvalitativ studie
Sisse Helle Njor,
Sirpa Heinävaara,
Hrefna Stefansdóttir,
Mari Nygård,
Eva María Guðmundsdóttir,
Sameer Bhargava
m.fl.:
Differences in mammography screening attendance among non-Western immigrants in Denmark, Finland, Iceland and Norway
Javier Louro,
Marta Román,
Nataliia Moshina,
Camilla Flåt Olstad,
Marthe Larsen,
Silje Sagstad
m.fl.:
Personalized Breast Cancer Screening: A Risk Prediction Model Based on Women Attending BreastScreen Norway
Helle Skjerven,
Even Moa Myklebust,
Christian Korvald,
Kjetil Stubberud,
Tone Hovda,
Alina Carmen Porojnicu
m.fl.:
Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study
European Journal of Surgical Oncology 2023 DOI
Fredrik Andreas Dahl,
Olav Brautaset,
Marit Holden,
Line Eikvil,
Marthe Larsen,
Solveig Sand-Hanssen Hofvind
:
A two-stage mammography classification model using explainable-AI for ROI detection
Nordic Machine Intelligence (NMI) 2023 DOI
Anders Skyrud Danielsen,
Petter Elstrøm,
Hanne-Merete Eriksen-Volle,
Solveig Sand-Hanssen Hofvind,
David W. Eyre,
Oliver Kacelnik
m.fl.:
The epidemiology of multidrug-resistant organisms in persons diagnosed with cancer in Norway, 2008–2018: expanding surveillance using existing laboratory and register data
Anouk H. Eijkelboom,
Marthe Larsen,
Sabine Siesling,
Jan Franz Nygård,
Solveig Sand-Hanssen Hofvind,
Linda de Munck
:
Prolonged screening interval due to the COVID-19 pandemic and its association with tumor characteristics and treatment; a register-based study from BreastScreen Norway
Jessie J.J. Gommers,
Craig K. Abbey,
Fredrik Strand,
Sian Taylor-Phillips,
David J. Jenkinson,
Marthe Larsen
m.fl.:
Optimizing the Pairs of Radiologists That Double Read Screening Mammograms
Marthe Larsen,
Camilla Flåt Olstad,
Henrik Wethe Koch,
Marit Almenning Martiniussen,
Solveig Kristin Roth Hoff,
Håkon Lund-Hanssen
m.fl.:
AI Risk Score on Screening Mammograms Preceding Breast Cancer Diagnosis
Jonas Evensen Thy,
Sameer Bhargava,
Marthe Larsen,
Lars Andreas Akslen,
Solveig Sand-Hanssen Hofvind
:
Early screening outcomes among non-immigrants and immigrants targeted by BreastScreen Norway, 2010–2019
Helle Skjerven,
Anders Skyrud Danielsen,
Ellen Schlichting,
Kristine Kleivi Sahlberg,
Solveig Sand-Hanssen Hofvind
:
Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 2018
Marit Almenning Martiniussen,
Silje Sagstad,
Marthe Larsen,
Anne Sofie Frøyshov Larsen,
Tone Hovda,
Christoph I. Lee
m.fl.:
Screen-detected and interval breast cancer after concordant and discordant interpretations in a population based screening program using independent double reading
Fredrik Andreas Dahl,
Olav Brautaset,
Marit Holden,
Line Eikvil,
Marthe Larsen,
Marit Almenning Martiniussen
m.fl.:
En to-trinns kunstig intelligens modell for deteksjon av brystkreft i mammogrammer
2024
Julie Røgler Langås,
Anne Eskild,
Solveig Sand-Hanssen Hofvind,
Elisabeth Krefting Bjelland
:
The association of adolescent to midlife weight change with age at natural menopause: a population study of 263,586 women in Norway.
Norsk Epidemiologi, Supplement 2024
Julie Røgler Langås,
Solveig Sand-Hanssen Hofvind,
Nathalie Charlotte Støer,
Anne Eskild,
Elisabeth Krefting Bjelland
:
Adolescent to midlife exercise trajectories and age at menopause: a population study of 246 147 women in Norway
Norsk Epidemiologi, Supplement 2024
Robert Jenssen,
Rolf Ole Lindsetmo,
Therese Hoseth Blomsø,
Solveig Sand-Hanssen Hofvind,
Even A. Røed,
Mathias K. Hauglid
m.fl.:
Hvordan implementerer vi KI for bruk i helsesektoren på en trygg måte?
2024
Julie Røgler Langås,
Anne Eskild,
Solveig Sand-Hanssen Hofvind,
Elisabeth Krefting Bjelland
:
The dose–response relationship of pre-menopausal alcohol consumption with age at menopause: a population study of 280 497 women in Norway
2023
De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →
